Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?

Dennison, Elaine M; Jameson, Karen A; Marks, Jonathan; Watson, Kath; Hyrich, Kimme; Symmons, Deborah; Cooper, Cyrus

Dennison, Elaine M; Jameson, Karen A; Marks, Jonathan; Watson, Kath; Hyrich, Kimme; Symmons, Deborah; Cooper, Cyrus.

Afiliación

Dennison EM; MRC Lifecourse Epidemiology Unit.
Jameson KA; MRC Lifecourse Epidemiology Unit.
Marks J; Rheumatology Research Unit, University Hospitals Trust Southampton, Southampton.
Watson K; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Manchester University.
Hyrich K; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Manchester University.
Symmons D; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester.
Cooper C; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Manchester University.

Rheumatology (Oxford) ; 56(4): 663-665, 2017 04 01.

Article en En | MEDLINE | ID: mdl-28039417

Asunto(s)

Artritis Reumatoide; Factor de Necrosis Tumoral alfa; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Factor de Necrosis Tumoral alfa Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2017 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google